rediff.com
e.g. Tata motors, Reliance MF, 500570
Lincoln Pharmaceuticals Ltd. - Research Center
531633 LINCOLN Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income
Operating income 580.55 510.31 472.08 413.06 376.09
Expenses
Material consumed 280.02 243.09 219.78 201.33 187.26
Manufacturing expenses 11.47 10.25 8.33 6.84 7.57
Personnel expenses 102.90 93.16 70.47 56.47 54.90
Selling expenses 1.03 1.16 0.06 0.05 0.19
Adminstrative expenses 85.22 73.48 77.96 67.02 66.80
Expenses capitalised - - - - -
Cost of sales 480.64 421.14 376.61 331.71 316.72
Operating profit 99.91 89.17 95.47 81.35 59.37
Other recurring income 34.42 22.48 10.00 6.77 12.13
Adjusted PBDIT 134.33 111.65 105.47 88.12 71.50
Financial expenses 1.46 2.03 1.45 1.44 1.98
Depreciation 10.62 9.17 8.09 5.67 5.47
Other write offs - - - - -
Adjusted PBT 122.24 100.46 95.93 81.01 64.05
Tax charges 28.94 27.56 26.57 20.61 14.48
Adjusted PAT 93.30 72.90 69.36 60.41 49.56
Non recurring items - -0.48 0.13 - -
Other non cash adjustments - - - - -
Reported net profit 93.30 72.42 69.49 60.41 49.56
Earnigs before appropriation 510.97 420.69 341.31 272.33 219.66
Equity dividend 3.00 3.00 3.00 - 4.77
Preference dividend - - - - -
Dividend tax - - - - 1.23
Retained earnings 507.96 417.68 338.31 272.33 213.66
Close
Add Lincoln Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Lincoln Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close